This document is a USPTO patent application (US20260083906A1) filed on September 21, 2024, for a novel thyroid hormone delivery device. The proposed device is designed for subcutaneous implantation and features a reservoir regulated by an embedded microprocessor and precision pump to ensure continuous and precisely dosed delivery of thyroxine at regular intervals.

While this is a patent application and not a regulation, it indicates potential future developments in medical devices for endocrine therapy. Companies involved in pharmaceutical manufacturing or medical device development, particularly those focused on drug delivery systems, should be aware of this technological advancement. There are no immediate compliance obligations or deadlines associated with this patent application.